Clinical response to thalidomide and colchicine in two siblings with Behcet’s disease carrying a single mutated MEFV allele

Koné-Paut I, Sanchez E, Le Quellec A, Manna R, Touitou I (2007) Autoinflammatory gene mutations in Behçet’s disease. Ann Rheum Dis 66:832–834PubMedCrossRefGoogle Scholar

Zierhut M, Mizuki N, Ohno S, Inoko H, Gül A, Onoé K, Isogai E (2003) Immunology and functional genomics of Behçet’s disease. Cell Mol Life Sci 60:1903–1922PubMedCrossRefGoogle Scholar

Touitou I, Magne X, Molinari N, Navarro A, Quellec AL, Picco P, Seri M, Ozen S, Bakkaloglu A, Karaduman A, Garnier JM, Demaille J, Koné-Paut I (2000) MEFV mutations in Behçet’s disease. Hum Mutat 16:271–272PubMedCrossRefGoogle Scholar

Rabinovich E, Shinar Y, Leiba M, Ehrenfeld M, Langevitz P, Livneh A (2007) Common FMF alleles may predispose to development of Behcet’s disease with increased risk for venous thrombosis. Scand J Rheumatol 36:48–52PubMedCrossRefGoogle Scholar

Schwartz T, Langevitz P, Zemer D, Gazit E, Pras M, Livneh A (2000) Behçet’s disease in familial Mediterranean fever: characterization of the association between the two diseases. Semin Arthritis Rheum 29:286–295PubMedCrossRefGoogle Scholar

Livneh A, Aksentijevich I, Langevitz P, Torosyan Y, G-Shoham N, Shinar Y, Pras E, Zaks N, Padeh S, Kastner DL, Pras M (2001) A single mutated MEFV allele in Israeli patients suffering from familial Mediterranean fever and Behçet’s disease (FMF-BD). Eur J Hum Genet 9:191–196PubMedCrossRefGoogle Scholar

Hamuryudan V, Hatemi G, Tascilar K, Sut N, Ozyazgan Y, Seyahi E, Mat C, Yurdakul S, Yazici H (2010) Prognosis of Behcet’s syndrome among men with mucocutaneous involvement at disease onset: long-term outcome of patients enrolled in a controlled trial. Rheumatology (Oxford) 49:173–177CrossRefGoogle Scholar

Evereklioglu C (2004) Managing the symptoms of Behçet’s disease. Expert Opin Pharmacother 5:317–328PubMedCrossRefGoogle Scholar